Life Tech Acquires AcroMetrix to Gain QC Reagents for Real-Time PCR, other Molecular Dx Assays
January 14, 2010
Life Tech Acquires AcroMetrix to Gain QC Reagents for Real-Time PCR, other Molecular Dx Assays
Life Tech officials said they expect the deal to complement its company's real-time PCR business in the short term and help expand its presence in the broader molecular diagnostics market in the longer term.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Revising Molecular Dx Roadmap, Qiagen Will Migrate PCR Tests Across Automated Platforms
May 12, 2011 / PCR Insider - Life Tech Buys QC Firm AcroMetrix
January 12, 2010 / GenomeWeb Daily News - Life Tech's Q1 Revenues Increase 2 Percent on Genetic Analysis, Applied Sciences Sales
May 3, 2013 / GenomeWeb Daily News - Life Tech Acquisition Would Make Thermo Fisher a Leader in PCR Research Tools, Forensic Analysis
April 18, 2013 / PCR Insider - JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark
January 9, 2013 / GenomeWeb Daily News